Pills masthead

News Releases

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010

20092008200720062004

Feb 6, 2019
- Recent 17 Product Launches Contributed $40 Million of Net Sales in Fiscal 2019 YTD

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2019 second quarter ended December 31, 2018. "Stellar sales across our product offering drove our strong fiscal...

More
Feb 6, 2019
Product Launches, Cost Savings, Insulin Glargine
Jan 30, 2019

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2019 second quarter on Wednesday, February 6, 2019, after the market closes. Lannett...

More
Jan 22, 2019
Company Has Begun Marketing Entacapone IR Tablets

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules,...

More
Dec 11, 2018
--Company Expects to be Well within Its Financial Covenants through the Maturity Date of the Term A Loans--

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an amendment of its credit agreement effecting the term A loans thereunder (Term A Loans) to provide the company greater...

More
Dec 5, 2018

Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2018 Prescription for Success Healthcare Conference on December 12, 2018 at 2:40 p.m....

More
Nov 12, 2018
--Lannett Locks in $50 Million of Gross Profit for 16-Week Period--

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals, Inc. (Amneal) with regard to Levothyroxine Sodium Tablets USP. Under the...

More
Nov 7, 2018
- Fiscal 2019 First Quarter Net Sales and Adjusted Net Income Ahead of Expectations

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2019 first quarter ended September 30, 2018. "For the fiscal 2019 first quarter, net sales and adjusted net income...

More
Nov 6, 2018
--Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019--

Lannett Company, Inc. (NYSE: LCI) today announced that it has expanded its agreement with Sunshine Lake LLC, the U.S. subsidiary of the HEC Pharm Group (HEC) of China, to be the exclusive...

More
 
Price Data
NYSELCI